SIGA Technologies has gained Japanese regulatory approval for TEPOXX (tecovirimat) 200mg capsules, known as TPOXX in the US, ...

SHELTON, CT / ACCESSWIRE / January 8, 2025 / Dr. Anil Diwan, President of NanoViricides, Inc. (NYSE American: NNVC) (the "Company"), ...

"SIGA’s antiviral approved in Japan for orthopoxvirus treatment" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand. The information on this site has ...

SHELTON, CT / ACCESSWIRE / January 8, 2025 / Dr. Anil Diwan, President of NanoViricides, Inc. (NYSE American: NNVC) (the "Company"), comments on the many viruses that could cause pandemics that are go ...

( MENAFN - IANS) Lusaka, Jan 4 (IANS) Zambia's health authorities have reported the country's fourth case of monkeypox, also ...

Here we describe historical, current and future therapies to treat orthopoxvirus diseases. Scott Parker, Department of Molecular Microbiology & Immunology, Saint Louis University Health Sciences ...

Tecovirimat did not improve time to lesion resolution compared with placebo in patients with mild to moderate mpox disease.

A 30-year-old man recently returning from West Africa was confirmed as a new case of mpox in Serbia on Friday. He is also the ...

SIGA Technologies receives Japanese approval for Tepoxx for the treatment of orthopoxviruses: New York Saturday, January 4, 2025, 12:00 Hrs [IST] SIGA Technologies, a commercial s ...